000			04298nam a22004095i 4500
999			_c368744 _d368744 _x1
001			368744
003			ES-MaUEC
005			20230102121804.0
006			a||||fo|||| 00| 0
007			cr nn nnnaamaa
008			220128s2022 sz | s |||| 0|eng d
020			_a9783030898915
024	7		_a10.1007/978-3-030-89891-5 _2doi
040			_aES-MaUEC _bspa _cES-MaUEC _dES-MaUEC
050		4	_aRC871 .U78 _b2022 EB
245	0	0	_aUrologic Oncology : _bMultidisciplinary Care for Patients _cedited by Kelly L. Stratton, Alicia K. Morgans
250			_aFirst edition 2022
264		1	_aCham _bSpringer International Publishing _c2022
300			_a1 recurso en línea (X, 491 páginas) _b30 ilustraciones, 23 ilustraciones a color
336			_2rdacontent _aTexto _btxt
337			_2rdamedia _aelectrónico _bc
338			_2rdacarrier _arecurso electrónico _bcr
347			_aarchivo de texto _bPDF
505	0		_aCreating a Multidisciplinary GU Cancer Clinic -- Supportive and Palliative Care for Genitourinary Malignancies -- Operationalizing Genetic Testing in the Care of Patients with Prostate Cancer -- High-Risk Prostate Cancer -- Treatment of Metastatic Hormone Sensitive Prostate Cancer -- Expanding Options for M0 Castration Resistant Prostate Cancer (CRPC) -- Immunotherapy for Metastatic Prostate Cancer -- Advances in Prostate Cancer Imaging -- Bone Health Management -- Radiotherapy for Advanced Prostate Cancer -- Optimizing Perioperative Treatment for Kidney Cancer -- Surgical Treatment for Metastatic Kidney Cancer -- Targeted Therapy for Renal Cell Carcinoma -- Hereditary Cancer and Genetics in Renal Cell Carcinoma -- Immunotherapy in Renal Cell Carcinoma -- Evolving Treatment in Non-Muscle Invasive Bladder Cancer -- Neoadjuvant and Adjuvant Therapy for Muscle-Invasive Bladder Cancer -- Bladder-Sparing Approaches to Treatment of Muscle-Invasive Bladder Cancer -- Treatment of Metastatic Bladder Cancer -- Treatment of Upper Tract Urothelial Carcinoma.
520			_aUrologists and medical oncologists have witnessed a rapid growth in systemic therapeutic options for treating genitourinary malignancies that increasingly integrates radiation therapy to primary cancers, nodal beds, and even metastatic sites. The culmination of these advances has been the creation of multidisciplinary teams that expertly provide comprehensive care to patients with urologic cancers. This book provides the framework to create such a multidisciplinary clinical team focused on the treatment of urologic malignancies with representation from urologists, medical oncologists, and additional specialists who work together to provide optimal team-based care. The book integrates advanced systemic therapeutics including immune-based and targeted therapies. Readers gain a better understanding of the benefit of multidisciplinary co-management through specific examples such as hormone sensitive metastatic prostate cancer, neoadjuvant chemotherapy for muscle invasive bladder cancer, and immunotherapy approaches to advanced bladder and kidney cancer. The book also discusses the integration of genomic tumor characterization and personalized medicine into surgical planning, tumor biopsies, and chemo-immunotherapy selection, emphasizing the expansion of new therapeutics for urologic malignancies and the changing definitions of disease progression. Urologic Oncology: Multidisciplinary Care for Patients is a comprehensive resource for urologists, medical oncologists, radiation oncologists, genetic counselors, fellows in urologic oncology and medical oncology, residents in urology and radiation oncology, advanced practice providers, practice managers, and pharmaceutical representatives.
988			_aSpringer_Medicine_2022
650		7	_2embne _9138565 _aUrología
650		7	_2embne _9139308 _aCáncer
700	1		_aStratton, Kelly L. _eeditor literario
700	1		_aMorgans, Alicia K. _eeditor literario
856	4	0	_uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-89891-5 _zAcceso a este recurso digital (usuarios Universidad Europea de Madrid)
942			_2lcc _cLE _n0
998			_b04/2022 _dz _eu _zSI